Inspire. Connect. Innovate.

Join us for the OneTRI Conference on Thursday 5 October 2023
9:00am - 5:45pm, TRI Auditorium and Zoom

About the Conference

The OneTRI Conference will showcase the translational research happening at TRI, propelling medical breakthroughs from laboratory to patient care.

The action-packed program features keynote presentations, abstract oral presentations and is centered around four pivotal themes. These sessions, led by local thought leaders, will focus on cutting edge research, technologies and interventions: 

Session 1: Careers in Focus: What and How?
Session 2: EMCRs in Focus
Session 3: Collaborations at TRI: Researcher linkage with the clinic or industry
Session 4: Cutting edge capabilities at TRI: Did you know?

Download the program below for more information.



Please email
Meet our OneTRI Conference Speakers
Speaker 1


Prof Antje Blumenthal

Research Group Leader (UQ)

Prof Antje Blumenthal leads the Infection & Inflammation Group at The University of Queensland Frazer Institute. She is an ARC Future Fellow and the Director of the Australian infectious Diseases Research Centre. The Blumenthal lab uses cutting-edge technologies in in vivo and in vitro model systems, and fosters cross-disciplinary collaborations across academia, clinical research teams and industry partners.

Speaker 2


Prof Elizabeth Powell

Hepatologist, Queensland Health

Prof Powell is a Consultant Hepatologist at Princess Alexandra Hospital, Director of the Centre for Liver Disease Research in the School of Medicine, The University of Queensland, Translational Research Institute and Clinical Director, QIMR Berghofer Medical Research Institute. 

Speaker 3


A/Prof Fernando Guimaraes

Group Leader, Frazer Institute

A/Prof. Fernando Guimaraes is the leader of the Translational Innate Immunotherapy Group at the Frazer Institute, University of Queensland. He completed his doctoral degree as part of the International PhD Program at Institute Pasteur (Paris, France) in 2012. His group researches aim to identify and translate the role of NK cells and develop novel immunotherapy approaches for different diseases. 

Speaker 4


Prof Gene Tyson

Professor and Director, QUT, Centre for Microbiome Research

Prof Gene Tyson is a microbial ecologist and expert in the development and application of meta-omic and bioinformatic approaches to understand complex microbial communities. Through the integration of these techniques, Tyson has made seminal contributions to the field, including the discovery of novel microbial lineages and the identification of key microorganisms that influence human and environmental health. 

Speaker 5


A/Prof Wayne Nicholls

Director, Oncology Services Group, Senior Staff Specialist, Paediatric Oncology, Children’s Health Queensland Hospital and Health Service

A/Prof Wayne Nicholls is the Director of the Oncology Services Group at the Queensland Children’s Hospital and the Clinical Director of the Ian Frazer Centre for Children’s Immunotherapy Research (UQ). His clinical and research interests are in paediatric, adolescent and young adult solid tumours. 

Speaker 6


Prof Katharina Ronacher

Head of the Infection, Immunity and Metabolism Group, Mater Research Institute, The University of Queensland

Prof Katharina Ronacher is Head of the Infection, Immunity and Metabolism Group at the Mater Research Institute – The University of Queensland. She is leading the international ALERT Consortium with clinical field sites in South Africa and at the Texas/Mexico border. Read more >>

Speaker 7


A/Prof Lucy Burr

Director of Respiratory and Sleep Medicine, Mater and Group Leader, Respiratory Research, Mater Research Institute, UQ

A/Prof Lucy Burr is an experienced respiratory physician, training supervisor and clinical trials researcher at Mater Health and Mater Research – University of Queensland (UQ). She has a PhD (2017) in bronchiectasis microbiology and is an Associate Professor at the School of Medicine, UQ. She is the Director of Respiratory, Sleep and Cystic Fibrosis medicine at the Mater Hospital, Brisbane.

Speaker 8


Dr Richard Gordon

Associate Professor of Neuroscience, Queensland University of Technology

Dr Richard Gordon leads a multi-disciplinary, industry-partnered research program in Translational Neuroscience which aims to understand and target key pathological mechanisms that drive the onset and progression of Parkinson’s disease and Amyotrophic Lateral Sclerosis.

Speaker 9


Prof Sailesh Kumar

Mayne Professor of Obstetrics & Gynaecology, Faculty of Medicine, University of Queensland and Mater Research Institute

Prof Kumar is a Senior Specialist in Maternal & Fetal Medicine/Obstetrics at the Mater Mothers’ Hospital and Royal Brisbane and Women’s Hospitals. He is also Visiting Professor at Imperial College London and the Queensland University of Technology.

Speaker 10


Dr Bryan Oronsky

Chief Development Officer, EpicentRx Inc

Dr. Bryan Oronsky is the Chief Medical Development Officer and combines firsthand clinical experience as a physician with 17 years of pharmaceutical development experience. He leads all clinical initiatives including the strategy, design and execution of clinical trials. 

Speaker 11


Scott Caroen

Senior Director of Operations & Corporate Development, EpicentRx Inc

Scott has over 10 years of experience in Clinical Program Development and Life Science Business Strategies. He is responsible for Global Operations, working directly with the Executive Team and helps to drive business development by prioritizing opportunities, conducting diligence, and transacting business and collaboration opportunities. Mr. Caroen is a co-author on over 40 peer reviewed scientific publications and co-inventor on 3 pending patents.

Speaker 12